Consensus on the tertiary prevention of primary liver cancer-Reference-Cited by-同舟云学术

Consensus on the tertiary prevention of primary liver cancer

Published:2023-06-27 Issue:5 Volume:17 Page:1057-1071
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Nan Yuemin^ORCID,Xu Xiaoyuan,Dong Shiming,Yang Ming,Li Ling,Zhao Suxian,Duan Zhongping,Jia Jidong,Wei Lai,Zhuang Hui,Chen Hongsong,Ding Huiguo,Duan Zhongping,Fan Jian-gao,Gao Yanhang,Hu He-ping,Huang Jianrong,Li Jun,Li Wencong,Li Wen-gang,Liu Jingfeng,Liu Lingdi,Nan Yuemin,Ren Wanhua,Shang Jia,Wang Maorong,Xie Wen,Zeng Mengsu,Zhang Yuguo,Zhao Jingmin,Zhao Shousong,Zhao Weifeng,Zhou Jian,

Abstract

AbstractTo effectively prevent recurrence, improve the prognosis and increase the survival rate of primary liver cancer (PLC) patients with radical cure, the Chinese Society of Hepatology, Chinese Medical Association, invited clinical experts and methodologists to develop the Consensus on the Tertiary Prevention of Primary Liver Cancer, which was based on the clinical and scientific advances on the risk factors, histopathology, imaging finding, clinical manifestation, and prevention of recurrence of PLC. The purpose is to provide a current basis for the prevention, surveillance, early detection and diagnosis, and the effective measures of PLC recurrence.

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-023-10549-2.pdf

Reference95 articles.

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. https://doi.org/10.3322/caac.21660

2. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075

3. Nan YM, Xu XY, Gao YH, et al. Consensus on the secondary prevention of primary liver cancer. Hep Int. 2021;15(6):1289–1300. https://doi.org/10.1007/s12072-021-10259-7

4. Tampaki M, Papatheodoridis GV, Cholongitas E. Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clin J Gastroenterol. 2021;14(3):699–713. https://doi.org/10.1007/s12328-021-01394-7

5. Yang SL, Luo YY, Chen M, et al. A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy. HPB (Oxford). 2017;19(10):835–842. https://doi.org/10.1016/j.hpb.2017.06.002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrence Pattern Is an Independent Surgical Prognostic Factor for Long-Term Oncological Outcomes in Patients with Hepatocellular Carcinoma;Biomedicines;2024-03-14

2. Association between blood lipid levels and the risk of liver cancer: a systematic review and meta-analysis;Cancer Causes & Control;2024-02-20

3. Assessing the causal relationship between mitochondria-associated proteins and chronic liver diseases：a comprehensive Mendelian randomisation study;2023-11-28